Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Terufumi Takagi
Observed name:
Takagi, Terufumi
Institution:
Takeda (Japan)
Observed institution:
Takeda (Japan)
OpenAlex ID:
A5047300316
Structure-Based Approach for the Discovery of Pyrrolo[3,2-d]pyrimidine-Based EGFR T790M/L858R Mutant Inhibitors
2012
·
Satoshi Sogabe
, Youichi Kawakita
, et al.
·
ACS Medicinal Chemistry Letters
·
186
Discovery of a Novel Pyrrole Derivative 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Fumarate (TAK-438) as a Potassium-Competitive Acid Blocker (P-CAB)
2012
·
Yasuyoshi Arikawa
, Haruyuki Nishida
, et al.
·
Journal of Medicinal Chemistry
·
161
Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d]pyrimidine derivatives: Novel VEGFR2 kinase inhibitors binding to inactive kinase conformation
2010
·
Yuya Oguro
, Naoki Miyamoto
, et al.
·
Bioorganic & Medicinal Chemistry
·
134
Discovery of a Selective Kinase Inhibitor (TAK-632) Targeting Pan-RAF Inhibition: Design, Synthesis, and Biological Evaluation of C-7-Substituted 1,3-Benzothiazole Derivatives
2013
·
Masanori Okaniwa
, Masaaki Hirose
, et al.
·
Journal of Medicinal Chemistry
·
118
Discovery of N-[5-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)-2-methylphenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide (TAK-593), a highly potent VEGFR2 kinase inhibitor
2013
·
Naoki Miyamoto
, Nozomu Sakai
, et al.
·
Bioorganic & Medicinal Chemistry
·
81
Design and Synthesis of Novel DFG-Out RAF/Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Inhibitors. 1. Exploration of [5,6]-Fused Bicyclic Scaffolds
2012
·
Masanori Okaniwa
, Masaaki Hirose
, et al.
·
Journal of Medicinal Chemistry
·
81
Currents in Computational Molecular Biology
2000
·
Julian Gough
, Satoru Miyano
, et al.
·
Bristol Research (University of Bristol)
·
75
Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers
2012
·
Haruyuki Nishida
, Atsushi Hasuoka
, et al.
·
Bioorganic & Medicinal Chemistry
·
49
Synthesis and Structure Activity Relationship Studies of Benzothieno[3,2-b]furan Derivatives as a Novel Class of IKK.BETA. Inhibitors
2007
·
Hideyuki Sugiyama
, Masato Yoshida
, et al.
·
Chemical and Pharmaceutical Bulletin
·
49
PDF
Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding Mode
2019
·
Jun Fujimoto
, Osamu Kurasawa
, et al.
·
ACS Medicinal Chemistry Letters
·
45
Discovery of a novel B-cell lymphoma 6 (BCL6)–corepressor interaction inhibitor by utilizing structure-based drug design
2017
·
Takeshi Yasui
, Takeshi Yamamoto
, et al.
·
Bioorganic & Medicinal Chemistry
·
41
PDF
N-Phenyl-N′-[4-(5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as novel inhibitors of VEGFR and FGFR kinases
2010
·
Yuya Oguro
, Naoki Miyamoto
, et al.
·
Bioorganic & Medicinal Chemistry
·
34
A Back-to-Front Fragment-Based Drug Design Search Strategy Targeting the DFG-Out Pocket of Protein Tyrosine Kinases
2012
·
Hidehisa Iwata
, Hideyuki Oki
, et al.
·
ACS Medicinal Chemistry Letters
·
33
High-throughput screening of small-molecules libraries identified antibacterials against clinically relevant multidrug-resistant A. baumannii and K. pneumoniae
2024
·
Benjamin Blasco
, Soojin Jang
, et al.
·
EBioMedicine
·
28
Design, synthesis, and evaluation of imidazo[1,2-b]pyridazine derivatives having a benzamide unit as novel VEGFR2 kinase inhibitors
2012
·
Naoki Miyamoto
, Yuya Oguro
, et al.
·
Bioorganic & Medicinal Chemistry
·
28
Design, Synthesis, and Biological Evaluation of Retinoic Acid-Related Orphan Receptor γt (RORγt) Agonist Structure-Based Functionality Switching Approach from In House RORγt Inverse Agonist to RORγt Agonist
2019
·
Tomoya Yukawa
, Yoshi Nara
, et al.
·
Journal of Medicinal Chemistry
·
27
Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy
2017
·
Akira Shibata
, Masako Kuno
, et al.
·
PLoS ONE
·
24
PDF
Structure-based design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine-based p38 MAP kinase inhibitors
2017
·
Akira Kaieda
, Masashi Takahashi
, et al.
·
Bioorganic & Medicinal Chemistry
·
23
PDF
Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors: 3. Evaluation of 5-amino-linked thiazolo[5,4-d]pyrimidine and thiazolo[5,4-b]pyridine derivatives
2012
·
Masaaki Hirose
, Masanori Okaniwa
, et al.
·
Bioorganic & Medicinal Chemistry
·
18
Synthesis and biological evaluation of the metabolites of 2-(1-{3-[(6-chloronaphthalen-2-yl)sulfonyl]propanoyl}piperidin-4-yl)-5-methyl-1,2-dihydro-3H-imidazo[1,5-c]imidazol-3-one
2009
·
Takuya Fujimoto
, Mamoru Tobisu
, et al.
·
Bioorganic & Medicinal Chemistry
·
18
Novel Method for the Evaluation of 3D Conformation Generators
2009
·
Terufumi Takagi
, Michiko Amano
, et al.
·
Journal of Chemical Information and Modeling
·
18
Prediction of Compound Bioactivities Using Heat-Diffusion Equation
2020
·
Tadashi Hidaka
, Keiko Imamura
, et al.
·
Patterns
·
16
PDF
Discovery, synthesis, and structure-activity relations of 3,4-dihydro-1H-spiro(naphthalene-2,2′-piperidin)-1-ones as potassium-competitive acid blockers
2017
·
Toshihiro Imaeda
, Koji Ono
, et al.
·
Bioorganic & Medicinal Chemistry
·
15
Discovery of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 Main Protease through Computer-Aided Drug Design
2025
·
Atsutoshi Okabe
, Daniel W. Carney
, et al.
·
Journal of Medicinal Chemistry
·
13
Structure‐Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5‐b]pyridin‐2‐one‐Based p38 MAP Kinase Inhibitors: Part 1
2019
·
Akira Kaieda
, Masashi Takahashi
, et al.
·
ChemMedChem
·
10
Show more works
View as search
Works count:
36
Citation count:
1,363
H-index:
18
I10-index:
26
Year
Topic
Type